PDT opportunities in oncology practice

The results of novel photosensitizer Photoditazine clinical trials have demonstrated high clinical potential of the drug in the PDT of 53 patients with malignant tumors. The drug has advantageous spectral, physico-chemical and energetic characteristics in comparison to currently used Russian and foreign photosensitizers.

[1]  H. Hansen,et al.  Lung cancer. , 1990, Cancer chemotherapy and biological response modifiers.